Skip to content

The effects of preventing premature LH surge in ovarian poor responders using GnRH antagonist and MPA: a RCT

the comparison of GnRH antagonist and MPA in preventing premature LH surge in poor responders

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17010906
Enrollment
Unknown
Registered
2017-03-18
Start date
2017-03-20
Completion date
Unknown
Last updated
2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

GnRH antagonist :GnRH antagonist
MPA :MPA

Sponsors

Shanghai Ninth People's Hospital affiliated Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 42 Years

Inclusion criteria

Inclusion criteria: 1. Women who have a history of infertility =1 year 2. Women aged >22 and <42 years 3. Women with spontaneous menstrual cycles of 21–35 days 4. Women who have at least one of the following indications for IVF or ICSI: tubal factor, male factor, diminished ovarian reserve, endometriosis or unexplained factors 5. Women diagnosed as poor responders according to the Bologna criteria, including at least two of the three following criteria: (1) Advanced age (=40 years) or any other risk factor for poor ovarian response; (2) A previous poor response with no more than three oocytes retrieved using the conventional stimulation protocols c. Abnormal ovarian reserve test results, including bilateral antral follicle counts <7 or serum antiMüllerian hormone <1.1 ng/ml.

Exclusion criteria

Exclusion criteria: 1. Clinically significant systemic diseases, such as renal failure and systemic lupus erythematosus; 2. Premature ovarian insufficiency; 3. Up to five previous unsuccessful IVF attempts; 4. Known Müllerian anomalies; 5. Any contraindications to ovarian stimulation treatments; 6. Unable to comply with the study procedures.

Design outcomes

Primary

MeasureTime frame
incidence of premature LH surge;

Secondary

MeasureTime frame
number of oocyte retrieved;number of viable embryos;

Countries

China

Contacts

Public ContactKuang Yanping

Shanghai Ninth People's Hospital affiliated Shanghai Jiaotong University School of Medicine

kuangyanp@126.com+86 021-53078108

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 5, 2026